Bank of America’s Wave Life Sciences WVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.72M Buy
236,760
+53,905
+29% +$702K ﹤0.01% 4213
2025
Q4
$3.11M Sell
182,855
-482,295
-73% -$4.9M ﹤0.01% 3726
2025
Q3
$4.87M Buy
665,150
+19,590
+3% +$158K ﹤0.01% 4044
2025
Q2
$4.2M Buy
645,560
+110,295
+21% +$728K ﹤0.01% 4077
2025
Q1
$4.32M Buy
535,265
+99,369
+23% +$1.09M ﹤0.01% 3962
2024
Q4
$5.39M Buy
435,896
+160,820
+58% +$2.15M ﹤0.01% 3523
2024
Q3
$2.26M Buy
275,076
+200,003
+266% +$1.2M ﹤0.01% 4464
2024
Q2
$375K Sell
75,073
-18,413
-20% -$105K ﹤0.01% 5523
2024
Q1
$577K Buy
93,486
+31,260
+50% +$157K ﹤0.01% 5270
2023
Q4
$314K Buy
62,226
+17,247
+38% +$92.2K ﹤0.01% 5806
2023
Q3
$259K Sell
44,979
-11,683
-21% -$53.3K ﹤0.01% 5743
2023
Q2
$206K Sell
56,662
-518,716
-90% -$2.1M ﹤0.01% 5806
2023
Q1
$2.49M Buy
575,378
+510,320
+784% +$2.34M ﹤0.01% 4164
2022
Q4
$455K Buy
65,058
+34,593
+114% +$159K ﹤0.01% 5452
2022
Q3
$110K Buy
30,465
+9,228
+43% +$30.6K ﹤0.01% 6302
2022
Q2
$69K Buy
21,237
+9,309
+78% +$17.9K ﹤0.01% 6672
2022
Q1
$24K Sell
11,928
-11,066
-48% -$27.1K ﹤0.01% 7456
2021
Q4
$73K Buy
22,994
+2,498
+12% +$10.4K ﹤0.01% 7031
2021
Q3
$100K Buy
20,496
+3,430
+20% +$20.8K ﹤0.01% 6728
2021
Q2
$114K Sell
17,066
-30,861
-64% -$202K ﹤0.01% 6446
2021
Q1
$268K Buy
47,927
+30,484
+175% +$293K ﹤0.01% 5823
2020
Q4
$137K Buy
17,443
+3,291
+23% +$27.6K ﹤0.01% 5828
2020
Q3
$120K Sell
14,152
-344
-2% -$3.77K ﹤0.01% 5590
2020
Q2
$151K Sell
14,496
-11,473
-44% -$108K ﹤0.01% 5436
2020
Q1
$244K Buy
25,969
+14,919
+135% +$127K ﹤0.01% 4975
2019
Q4
$89K Sell
11,050
-4,078
-27% -$100K ﹤0.01% 6041
2019
Q3
$311K Sell
15,128
-17,182
-53% -$394K ﹤0.01% 5394
2019
Q2
$843K Buy
32,310
+4,682
+17% +$131K ﹤0.01% 4692
2019
Q1
$1.07M Buy
27,628
+16,362
+145% +$664K ﹤0.01% 4466
2018
Q4
$473K Buy
11,266
+7,746
+220% +$344K ﹤0.01% 4975
2018
Q3
$176K Buy
3,520
+689
+24% +$31.1K ﹤0.01% 5552
2018
Q2
$108K Sell
2,831
-5,010
-64% -$216K ﹤0.01% 5759
2018
Q1
$315K Buy
7,841
+4,431
+130% +$186K ﹤0.01% 5118
2017
Q4
$119K Buy
3,410
+1,658
+95% +$48.3K ﹤0.01% 5671
2017
Q3
$38K Buy
1,752
+1,562
+822% +$31.4K ﹤0.01% 6048
2017
Q2
$3K Sell
190
-1,116
-85% -$24.1K ﹤0.01% 6690
2017
Q1
$36K Buy
1,306
+289
+28% +$8.07K ﹤0.01% 6075
2016
Q4
$27K Buy
1,017
+710
+231% +$23.1K ﹤0.01% 6215
2016
Q3
$10K Buy
307
+67
+28% +$1.58K ﹤0.01% 6396
2016
Q2
$5K Sell
240
-799
-77% -$12.4K ﹤0.01% 6683
2016
Q1
$14K Buy
+1,039
New +$14.5K ﹤0.01% 6280

Other funds holding WVE

Bank of America's WVE Position: Q1 2026 in Review

Bank of America increased its Wave Life Sciences (WVE) stake by 29% in Q1 2026, buying an estimated $702K and bringing the position to 236,760 shares worth $1.72M. The position accounts for ﹤0.01% of the portfolio, ranked #4213.

Bank of America first reported a position in WVE in Q1 2016 and has held it in 41 quarters since. The position peaked at $5.39M in Q4 2024. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • Bank of America held 236,760 shares of Wave Life Sciences worth $1.72M as of Q1 2026.
  • Bank of America bought 53,905 Wave Life Sciences shares in Q1 2026, an estimated $702K.
  • Wave Life Sciences made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4213 holding.
  • Bank of America first reported a position in Wave Life Sciences in Q1 2016 and has held it in 41 quarters since.
  • Bank of America's Wave Life Sciences position peaked at $5.39M in Q4 2024.
  • 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.